Halozyme Therapeutics Inc. buy Morgan Stanley
Start price
06.08.25
/
50%
€54.00
Target price
06.08.26
€64.83
Performance (%)
8.52%
Price
30.12.25
€58.60
Summary
This prediction is currently active. With a performance of 8.52%, the BUY prediction by Morgan_Stanley for Halozyme Therapeutics Inc. is trending in the right direction. This prediction currently runs until 06.08.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Halozyme Therapeutics Inc. | 1.034% | 1.034% |
| iShares Core DAX® | 0.794% | 2.841% |
| iShares Nasdaq 100 | 0.016% | -0.939% |
| iShares Nikkei 225® | 0.309% | -0.648% |
| iShares S&P 500 | 0.181% | -0.442% |
Comments by Morgan_Stanley for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics, Inc. (NASDAQ: HALO) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $75.00 price target on the stock, up previously from $62.00.
Ratings data for HALO provided by MarketBeat
Stopped prediction by Morgan_Stanley for Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€57.80
20.10.25
20.10.25
€67.75
20.10.26
20.10.26
1.38%
30.12.25
30.12.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€58.38
18.08.25
18.08.25
€68.36
18.08.26
18.08.26
0.38%
30.12.25
30.12.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€49.79
07.08.24
07.08.24
€58.59
07.08.25
07.08.25
6.69%
08.08.25
08.08.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€34.03
26.12.23
26.12.23
€53.50
26.12.24
26.12.24
34.94%
27.12.24
27.12.24
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€40.11
10.08.23
10.08.23
€55.35
10.08.24
10.08.24
26.55%
11.08.24
11.08.24
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€42.50
06.03.23
06.03.23
€60.06
06.03.24
06.03.24
-10.61%
07.03.24
07.03.24